23. プリオン病 Disease details / Clinical trials / Drug dev / DR info /
臨床試験数 : 8 / 薬物数 : 13 - (DrugBank : 3) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Bassado
IST. DI RICERCHE FARMACOLOG. M. NEGRI
2011 Phase 3 EUCTR2010-022233-28-IT Italy
Bassado 10CPS 100MG
ISTITUTO NEUROLOGICO CARLO BESTA
2006 - EUCTR2006-001858-27-IT Italy
Blood or buccal sample
University of Edinburgh
2016 - NCT02629640 United Kingdom
Clinical assessment and review
University of Edinburgh
2016 - NCT02629640 United Kingdom
Doxycycline
ISTITUTO NEUROLOGICO CARLO BESTA
2006 - EUCTR2006-001858-27-IT Italy
Doxycycline hyclate
IST. DI RICERCHE FARMACOLOG. M. NEGRI
2011 Phase 3 EUCTR2010-022233-28-IT Italy
Efavirenz
Xuanwu Hospital, Beijing
2026 Phase 3 NCT07482085 China
ION717
Ionis Pharmaceuticals, Inc.
2024 Phase 1/Phase 2 NCT06153966 Australia;Canada;France;Germany;Israel;Italy;Japan;Spain;United States
Medical history questionnaire
University of Edinburgh
2016 - NCT02629640 United Kingdom
Participant follow-UP
University of Edinburgh
2016 - NCT02629640 United Kingdom
Post mortem examination
University of Edinburgh
2016 - NCT02629640 United Kingdom
PRP-sirna
Broad Institute of MIT and Harvard
2026 Phase 1 NCT07444580 United States
Quinacrine
Medical Research Council
2004 - NCT00104663 United Kingdom
University of California, San Francisco
2005 Phase 2 NCT00183092 United States
IST. DI RICERCHE FARMACOLOG. M. NEGRI
2011 Phase 3 EUCTR2010-022233-28-IT Italy
Bassado 10CPS 100MG
ISTITUTO NEUROLOGICO CARLO BESTA
2006 - EUCTR2006-001858-27-IT Italy
Blood or buccal sample
University of Edinburgh
2016 - NCT02629640 United Kingdom
Clinical assessment and review
University of Edinburgh
2016 - NCT02629640 United Kingdom
Doxycycline
ISTITUTO NEUROLOGICO CARLO BESTA
2006 - EUCTR2006-001858-27-IT Italy
Doxycycline hyclate
IST. DI RICERCHE FARMACOLOG. M. NEGRI
2011 Phase 3 EUCTR2010-022233-28-IT Italy
Efavirenz
Xuanwu Hospital, Beijing
2026 Phase 3 NCT07482085 China
ION717
Ionis Pharmaceuticals, Inc.
2024 Phase 1/Phase 2 NCT06153966 Australia;Canada;France;Germany;Israel;Italy;Japan;Spain;United States
Medical history questionnaire
University of Edinburgh
2016 - NCT02629640 United Kingdom
Participant follow-UP
University of Edinburgh
2016 - NCT02629640 United Kingdom
Post mortem examination
University of Edinburgh
2016 - NCT02629640 United Kingdom
PRP-sirna
Broad Institute of MIT and Harvard
2026 Phase 1 NCT07444580 United States
Quinacrine
Medical Research Council
2004 - NCT00104663 United Kingdom
University of California, San Francisco
2005 Phase 2 NCT00183092 United States
